Articles
Effect of Salicylate on Serum Protein Binding and Red Blood Cell Uptake of Acetazolamide In Vitro

https://doi.org/10.1002/jps.2600770906Get rights and content

Abstract

The diffusion of acetazolamide from buffered saline and buffered albumin solutions into human erythrocytes has been characterized. A model was developed for describing the effects of both intra- and extracellular binding on the approach to distributional equilibrium. Unbound acetazolamide entered the cells via an apparent first-order process at a rate that was unaffected by salicylate at a therapeutic concentration of 200 μg/mL. Salicylate concentrations ranging from ~100 to 400 μg/mL were, however, extremely effective in displacing acetazolamide from its serum protein binding sites. Free fractions of acetazolamide in human serum were found to increase by an order of magnitude as salicylate concentrations approached 400 μg/mL, thereby greatly increasing the concentration of unbound drug available for passive diffusion into cells. The results indicate that while competitive binding effects, which may alter unbound drug concentration–time profiles and potentially impact on toxicity, do occur, alterations in red cell membrane permeability, which could adversely affect carbon dioxide transport, are not of significance.

References and Notes (17)

  • NishihataT. et al.

    Life Sci.

    (1984)
  • ChapronD.J. et al.

    J. Pharm. Sci.

    (1984)
  • TaylorP.

    J. Pharm. Sci.

    (1975)
  • BayneW.F. et al.

    J. Pharm. Sci.

    (1979)
  • ShahV.P. et al.

    J. Pharm. Sci.

    (1974)
  • SweeneyK. et al.

    Clin. Pharm. Ther.

    (1986)
  • ChapronD. et al.

    Br. J. Clin. Pharm.

    (1985)
  • Rowland, M.; Tozer, T. Clinical Phurmacokinetics; Lea and Febieer: Philadelohia: D...
There are more references available in the full text version of this article.

Cited by (10)

  • Drug-drug interactions and their implications on the pharmacokinetics of the drugs

    2022, Pharmacokinetics and Toxicokinetic Considerations - Vol II
  • Inhibition of carbonic anhydrase IX in glioblastoma multiforme

    2016, European Journal of Pharmaceutics and Biopharmaceutics
    Citation Excerpt :

    The enhanced effectiveness of ATZ micelles is likely because of ATZ protection and slow release in tumor. Secondly, as opposed to free ATZ which can diffuse in and out of the cells [58], ATZ micelles are retained for a longer time period. Thirdly, unincorporated ATZ precipitates in aqueous medium (whereas micelle-incorporated ATZ does not).

  • Drug-protein binding studies new trends in analytical and experimental methodology

    1996, Journal of Chromatography B: Biomedical Applications
  • Acetazolamide

    1993, Analytical Profiles of Drug Substances and Excipients
  • Determination of acetazolamide in human serum by enzymatic assay

    1992, Journal of Pharmacological and Toxicological Methods
View all citing articles on Scopus
View full text